Instil Bio (TIL) Enterprise Value (2020 - 2026)
Instil Bio (TIL) posted quarterly Enterprise Value of -$5.0 million for Q1 2026, up 67.32% year-over-year from -$3.0 million in Q1 2025, and up 24.34% quarter-over-quarter from -$6.6 million in Q4 2025.
Instil Bio (TIL) Enterprise Value (2020 - 2026) Analysis & Trends
Instil Bio's Enterprise Value history runs 7 years deep, the most recent figure standing at -$5.0 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 67.32% year-over-year to -$5.0 million; the TTM figure through Mar 2026 stood at -$5.0 million (up 67.32% YoY), while the FY2025 annual figure was -$6.6 million, up 24.61% from the prior year.
- Enterprise Value for Q1 2026 stood at -$5.0 million, up from -$6.6 million in the prior quarter.
- The five-year high for Enterprise Value was -$5.0 million in Q1 2026, with the low at -$379.5 million in Q1 2022.
- The 5-year median for Enterprise Value is -$15.4 million (2025), against an average of -$125.0 million.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value jumped 97.54% in 2024, then tumbled 180.2% in 2025.
- Instil Bio's Enterprise Value stood at -$260.9 million in 2022, then surged by 42.37% to -$150.4 million in 2023, then jumped by 94.14% to -$8.8 million in 2024, then advanced by 24.61% to -$6.6 million in 2025, then increased by 24.34% to -$5.0 million in 2026.
- Business Quant data shows TIL's Enterprise Value at -$5.0 million in Q1 2026, -$6.6 million in Q4 2025, and -$5.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 2.12 Bn |
| 10 | Instil Bio | 53.44 Mn | 53.44 Mn | - | -5.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.54 Mn |
| Mar 31, 2026 | -5.02 Mn |
| Dec 31, 2025 | -6.64 Mn |
| Sep 30, 2025 | -5.80 Mn |
| Jun 30, 2025 | -7.69 Mn |
| Mar 31, 2025 | -15.37 Mn |
| Dec 31, 2024 | -8.81 Mn |
| Sep 30, 2024 | -6.66 Mn |
| Jun 30, 2024 | -6.78 Mn |
| Mar 31, 2024 | -5.48 Mn |
| Dec 31, 2023 | -150.36 Mn |
| Sep 30, 2023 | -183.45 Mn |
| Jun 30, 2023 | -201.70 Mn |
| Mar 31, 2023 | -223.20 Mn |
| Dec 31, 2022 | -260.92 Mn |
| Sep 30, 2022 | -303.29 Mn |
| Jun 30, 2022 | -354.61 Mn |
| Mar 31, 2022 | -379.52 Mn |
| Dec 31, 2021 | -454.10 Mn |
| Sep 30, 2021 | -515.36 Mn |